genomic testing Archives

TAG:

genomic testing

Anthem Launches Program to Manage Genetic Tests

By R. Lewis Dark | From the Volume XXIV No. 9 – June 26, 2017 Issue

CEO SUMMARY: Pre-authorization of genetic tests is coming to physicians serving patients insured by Anthem, Inc. Its specialty benefits management company, AIM Specialty Health, will manage the program. AIM will work with InformedDNA, a company that specializes in genetic testing clinical…

Pharmacogenomic testing a success at South Dakota health system

By Mary Van Doren | From the Volume XXIV No. 2 – January 30, 2017 Issue

This is an excerpt from a 2,700-word article in the January 30 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: One es…

Health System Lab Is Genotyping To Identify Best Drugs for Patients

By Joseph Burns | From the Volume XXIV No. 2 – January 30, 2017 Issue

CEO SUMMARY: One essential element of precision medicine will be the regular use of pharmacogenomic testing to provide additional guidance to physicians when selecting the most appropriate therapeutics and optimal dose for each individual patient. Despite the reluctance of private payers …

Another Pharmacogenomic Lab Hit With Audit, Multi-million Dollar Repayment Demand

By Joseph Burns | From the Volume XXIV No. 2 – January 30, 2017 Issue

CEO SUMMARY: In 2014, during a ZPIC audit of an unnamed pharmacogenomic testing lab, a federal auditor reviewed a small number of claims that had been filed over a period of several years. Despite supporting letters from physicians, the auditor rejected those claims, then extrapolated the…

Pharmacogenomic Testing Draws $26 Million Recoupment from Medicare Audit

By Mary Van Doren | From the Volume XXIV No. 1 – January 9, 2017 Issue

This is an excerpt from a 1,340-word article in the January 9 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: Phar…

$26 Million Recoupment from Medicare Audit Hammers Pharmacogenomic Lab

By Joseph Burns | From the Volume XXIV No. 1 – January 9, 2017 Issue

CEO SUMMARY: After Pharmacogenetics Diagnostic Laboratory LLC was audited by a Medicare Zone Program Integrity Contractor (ZPIC), it faced a $26 million repayment demand. The lab company appealed and asked for a redetermination, then filed for Chapter 11 bankruptcy protection. These devel…

Genetic Testing Lab Finds Payers Respond To Education on Test Utility

By Joseph Burns | From the Volume XXIII No. 8 – June 13, 2016 Issue

CEO SUMMARY: In recent years, insurers have raised the bar and become much tougher when making coverage and reimbursement decisions for molecular assays, genomic, and genetic tests. Yet several lab testing companies are having good success at demonstrating the validity and clinical utilit…

2015’s Top 10 Lab Stories Show Significant Changes

By Robert Michel | From the Volume XXII, Number 18 – December 28, 2015 Issue

CEO SUMMARY: During 2015, two stories captured the full attention of most pathologists and clinical lab managers. One was how CMS intends to gather lab price market data as mandated by PAMA. The other was the continued efforts by the FDA to move ahead on proposed guidance for regulation o…

Medicare Ends Coverage for Genetic Drug-Sensitivity Tests

By Joseph Burns | From the Volume XXII NO. 9 – June 22, 2015 Issue

CEO SUMMARY: Medicare’s decision to cease covering many pharmacogenomic tests puts as many as 19 million Americans who have genetic variations affecting their response to medications at risk. These medications are commonly prescribed for patients with cardiovascular disease, pain…

Medicare Ends Coverage for Some Pharmacogenomic Testing

By Mary Van Doren | From the Volume XXII NO. 9 – June 22, 2015 Issue

WHAT THE FEDERAL GOVERNMENT giveth with one hand, it will often taketh away with the other hand. It might be argued that this is true of federal support of pharmacogenomic testing — particularly for those tests clinical labor…

Volume XXXI, No. 14 – October 14, 2024

For the second time in the past 16 months, respected health systems have taken steps to collaborate specifically to advance value-based care. Also, several statewide pilot programs—each involving tens of thousands of newborns—are publishing studies that demonstrate how exome, whole genome sequencing, and rapid whole genome sequencing can deliver both improved patient outcomes and a return on investment.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Topics

Visit The Dark Library

TAG:

genomic testing

CURRENT ISSUE

How Much Laboratory Business Intelligence Have You Missed?

Sign up for TDR Insider

Topics